This article was originally published in The Tan Sheet
Executive SummaryEleven proposed monographs for dietary supplements have been released for public comment, the U.S. Pharmacopeia states Nov. 15. Six turmeric-related monographs, three soy isoflavones monographs and two monographs for single ingredient amino acid formulations contain specific and validated analytical methods that will ensure the identify of the articles and protect consumers and industry from low-quality and adulterated products, USP says. Separately, USP announces Nov. 12 that it has completed a review of IVC Industries' B-50 Tablets and concluded the product does contain the amount of folic acid stated on its label and does meet USP dissolution requirements. USP conducted its assessment after ConsumerLab.com identified B-50 tablets as one of 10 multivitamins that do not contain label amounts of folic acid. B-50 Tablets are part of USP's Dietary Supplement Verification Program and carries the USP Verified mark...
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.